Advertisement

Topics

FDA accepts Teva, Celltrion's BLA for Rituxan biosimilar

06:16 EDT 30 Jun 2017 | SmartBrief

The FDA has accepted Celltrion and Teva Pharmaceutical Industries' biologics license application for CT-P10, a biosimilar to  -More

Original Article: FDA accepts Teva, Celltrion's BLA for Rituxan biosimilar

NEXT ARTICLE

More From BioPortfolio on "FDA accepts Teva, Celltrion's BLA for Rituxan biosimilar"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...